KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
KNTE
Delisted
KNTE was delisted on the 2nd of April, 2024.
76 hedge funds and large institutions have $465M invested in Kinnate Biopharma Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
38% less capital invested
Capital invested by funds: $750M → $465M (-$285M)
Holders
76
Holding in Top 10
6
Calls
$518K
Puts
–
Top Buyers
| 1 | +$7.8M | |
| 2 | +$7.56M | |
| 3 | +$2.2M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$1.19M |
| 5 |
HF
HRT Financial
New York
|
+$1.03M |
Top Sellers
| 1 | -$13.7M | |
| 2 | -$11.9M | |
| 3 | -$7.3M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.26M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$4.68M |